United Therapeutics (UTHR)
547.69
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 UNITED THERAPEUTICS Corp For: Jun 04 Filed by: MAHON PAUL A
June 4, 2026 5:31 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Jun 03 Filed by: ROTHBLATT MARTINE A
June 4, 2026 4:31 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: MAHON PAUL A
June 4, 2026 4:11 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Jun 02 Filed by: ROTHBLATT MARTINE A
June 3, 2026 4:35 PM - SEC Filing
Form SD UNITED THERAPEUTICS Corp
June 2, 2026 5:07 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Jun 01 Filed by: ROTHBLATT MARTINE A
June 2, 2026 4:34 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Jun 01 Filed by: EDGEMOND JAMES
June 2, 2026 4:33 PM - SEC Filing
Form 4/A UNITED THERAPEUTICS Corp For: May 26 Filed by: ROTHBLATT MARTINE A
June 2, 2026 4:33 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: ROTHBLATT MARTINE A
June 1, 2026 4:46 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 29 Filed by: ROTHBLATT MARTINE A
June 1, 2026 4:34 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 28 Filed by: EDGEMOND JAMES
May 29, 2026 4:38 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 28 Filed by: ROTHBLATT MARTINE A
May 29, 2026 4:37 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 27 Filed by: ROTHBLATT MARTINE A
May 28, 2026 5:13 PM - SEC Filing
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
May 28, 2026 4:07 PM - StreetInsider
Form 4 UNITED THERAPEUTICS Corp For: May 26 Filed by: EDGEMOND JAMES
May 27, 2026 4:32 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 26 Filed by: ROTHBLATT MARTINE A
May 27, 2026 4:31 PM - SEC Filing
United Therapeutics Corporation to Present at the Jefferies Global Healthcare Conference
May 27, 2026 7:00 AM - BizWire
Form 4 UNITED THERAPEUTICS Corp For: May 26 Filed by: ROTHBLATT MARTINE A
May 26, 2026 4:45 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 22 Filed by: ROTHBLATT MARTINE A
May 26, 2026 4:44 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 21 Filed by: EDGEMOND JAMES
May 22, 2026 5:16 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 21 Filed by: ROTHBLATT MARTINE A
May 22, 2026 4:46 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 20 Filed by: ROTHBLATT MARTINE A
May 21, 2026 4:35 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 21 Filed by: MAHON PAUL A
May 21, 2026 4:34 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: MAHON PAUL A
May 21, 2026 4:19 PM - SEC Filing
TD Cowen: 'United Therapeutics Corp. (UTHR) Remains a Top Idea'
May 21, 2026 9:09 AM - StreetInsider
TD Cowen: 'United Therapeutics Corp. (UTHR) Remains a Top Idea'
May 21, 2026 9:09 AM - StreetInsider
Form 4 UNITED THERAPEUTICS Corp For: May 19 Filed by: ROTHBLATT MARTINE A
May 20, 2026 4:34 PM - SEC Filing
JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms
May 20, 2026 3:10 PM - StreetInsider
JPMorgan Reinstates United Therapeutics Corp. (UTHR) at Overweight
May 20, 2026 4:30 AM - StreetInsider
Form 4 UNITED THERAPEUTICS Corp For: May 18 Filed by: EDGEMOND JAMES
May 19, 2026 4:33 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 18 Filed by: ROTHBLATT MARTINE A
May 19, 2026 4:32 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 15 Filed by: ROTHBLATT MARTINE A
May 18, 2026 6:18 PM - SEC Filing
United Therapeutics' Tyvaso meets primary endpoint in IPF study
May 18, 2026 4:15 PM - StreetInsider
United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026
May 18, 2026 4:15 PM - BizWire
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
May 17, 2026 2:15 PM - BizWire
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
May 15, 2026 6:00 PM - BizWire
Form 4 UNITED THERAPEUTICS Corp For: May 14 Filed by: ROTHBLATT MARTINE A
May 15, 2026 5:05 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 14 Filed by: EDGEMOND JAMES
May 15, 2026 5:04 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 13 Filed by: BENKOWITZ MICHAEL
May 14, 2026 5:55 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 13 Filed by: ROTHBLATT MARTINE A
May 14, 2026 5:55 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 12 Filed by: ROTHBLATT MARTINE A
May 13, 2026 4:32 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 12 Filed by: Mesa Nilda
May 13, 2026 4:31 PM - SEC Filing
Varda Space and United Therapeutics partner for space-based drug development
May 13, 2026 6:01 AM - StreetInsider
Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease
May 13, 2026 6:00 AM - PR NewsWire
Form 4 UNITED THERAPEUTICS Corp For: May 11 Filed by: ROTHBLATT MARTINE A
May 12, 2026 5:26 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 11 Filed by: EDGEMOND JAMES
May 12, 2026 5:25 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: Mesa Nilda
May 12, 2026 5:16 PM - SEC Filing
United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference
May 12, 2026 7:00 AM - BizWire
Form 4 UNITED THERAPEUTICS Corp For: May 08 Filed by: ROTHBLATT MARTINE A
May 11, 2026 4:31 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 07 Filed by: EDGEMOND JAMES
May 11, 2026 7:38 AM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 07 Filed by: ROTHBLATT MARTINE A
May 11, 2026 7:37 AM - SEC Filing
United Therapeutics to present 12 studies at ATS 2026 conference
May 11, 2026 6:30 AM - StreetInsider
United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026
May 11, 2026 6:30 AM - BizWire
Form 4 UNITED THERAPEUTICS Corp For: May 07 Filed by: MAHON PAUL A
May 7, 2026 4:33 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 06 Filed by: ROTHBLATT MARTINE A
May 7, 2026 4:33 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: MAHON PAUL A
May 7, 2026 4:05 PM - SEC Filing
United Therapeutics Corp. (UTHR) PT Lowered to $516 at Morgan Stanley
May 7, 2026 9:02 AM - StreetInsider
United Therapeutics Corp. (UTHR) PT Lowered to $701 at RBC Capital
May 7, 2026 8:30 AM - StreetInsider
Wells Fargo Upgrades United Therapeutics Corp. (UTHR) to Overweight
May 7, 2026 5:11 AM - StreetInsider
Form 4 UNITED THERAPEUTICS Corp For: May 05 Filed by: ROTHBLATT MARTINE A
May 6, 2026 5:06 PM - SEC Filing
BTIG on United Therapeutics Corp. (UTHR): 'We believe Yutrepia likely sees positive readthrough from this data'
May 6, 2026 1:20 PM - StreetInsider
United Therapeutics (UTHR) Misses Q1 EPS by 117c
May 6, 2026 6:32 AM - StreetInsider
Form 8-K UNITED THERAPEUTICS Corp For: May 06
May 6, 2026 6:32 AM - SEC Filing
Form 10-Q UNITED THERAPEUTICS Corp For: Mar 31
May 6, 2026 6:31 AM - SEC Filing
MannKind develops dry powder inhaler for pulmonary hypertension treatment
May 6, 2026 6:31 AM - StreetInsider
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
May 6, 2026 6:30 AM - Globe NewsWire
United Therapeutics Corporation Reports First Quarter 2026 Financial Results
May 6, 2026 6:30 AM - BizWire
Form 4 UNITED THERAPEUTICS Corp For: May 04 Filed by: ROTHBLATT MARTINE A
May 5, 2026 4:32 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 04 Filed by: EDGEMOND JAMES
May 5, 2026 4:31 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: May 01 Filed by: ROTHBLATT MARTINE A
May 4, 2026 4:55 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: EDGEMOND JAMES
May 4, 2026 4:52 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 30 Filed by: ROTHBLATT MARTINE A
May 1, 2026 4:57 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 30 Filed by: EDGEMOND JAMES
May 1, 2026 4:57 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: ROTHBLATT MARTINE A
May 1, 2026 4:47 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 29 Filed by: ROTHBLATT MARTINE A
April 30, 2026 4:32 PM - SEC Filing
Form SCHEDULE 13G UNITED THERAPEUTICS Corp Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 2:37 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 28 Filed by: ROTHBLATT MARTINE A
April 29, 2026 4:33 PM - SEC Filing
United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors
April 29, 2026 7:00 AM - BizWire
Form ARS UNITED THERAPEUTICS Corp For: Dec 31
April 29, 2026 6:37 AM - SEC Filing
Form DEFA14A UNITED THERAPEUTICS Corp
April 29, 2026 6:36 AM - SEC Filing
Form DEF 14A UNITED THERAPEUTICS Corp For: Jun 26
April 29, 2026 6:35 AM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 27 Filed by: ROTHBLATT MARTINE A
April 28, 2026 6:04 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 27 Filed by: EDGEMOND JAMES
April 28, 2026 5:30 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 24 Filed by: ROTHBLATT MARTINE A
April 27, 2026 4:40 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 23 Filed by: EDGEMOND JAMES
April 24, 2026 4:34 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 23 Filed by: ROTHBLATT MARTINE A
April 24, 2026 4:33 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 24 Filed by: PATUSKY CHRISTOPHER
April 24, 2026 4:32 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: PATUSKY CHRISTOPHER
April 24, 2026 4:02 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 22 Filed by: ROTHBLATT MARTINE A
April 23, 2026 7:04 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 21 Filed by: ROTHBLATT MARTINE A
April 22, 2026 4:32 PM - SEC Filing
United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026
April 22, 2026 7:00 AM - BizWire
Form 4 UNITED THERAPEUTICS Corp For: Apr 20 Filed by: ROTHBLATT MARTINE A
April 21, 2026 7:42 AM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 20 Filed by: EDGEMOND JAMES
April 21, 2026 7:41 AM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 17 Filed by: ROTHBLATT MARTINE A
April 20, 2026 4:38 PM - SEC Filing
United Therapeutics presents study data at transplant conference
April 20, 2026 6:31 AM - StreetInsider
United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026
April 20, 2026 6:30 AM - BizWire
Form 4 UNITED THERAPEUTICS Corp For: Apr 17 Filed by: PATUSKY CHRISTOPHER
April 17, 2026 4:58 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 16 Filed by: ROTHBLATT MARTINE A
April 17, 2026 4:57 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 16 Filed by: EDGEMOND JAMES
April 17, 2026 4:56 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: PATUSKY CHRISTOPHER
April 17, 2026 4:08 PM - SEC Filing
Increasing unusual option volume: UTHR KIE VSAT CP KBWB CM HUN ORBS BZAI CENX
April 17, 2026 10:44 AM - StreetInsider
Form 4 UNITED THERAPEUTICS Corp For: Mar 13 Filed by: ROTHBLATT MARTINE A
April 16, 2026 4:32 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 16 Filed by: MAHON PAUL A
April 16, 2026 4:31 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: MAHON PAUL A
April 16, 2026 4:02 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 13 Filed by: ROTHBLATT MARTINE A
April 14, 2026 4:35 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 13 Filed by: EDGEMOND JAMES
April 14, 2026 4:34 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 10 Filed by: ROTHBLATT MARTINE A
April 13, 2026 4:32 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 09 Filed by: EDGEMOND JAMES
April 10, 2026 4:33 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 09 Filed by: ROTHBLATT MARTINE A
April 10, 2026 4:33 PM - SEC Filing
United Therapeutics Corp. (UTHR) PT Raised to $519 at Morgan Stanley
April 10, 2026 8:16 AM - StreetInsider
Form 4 UNITED THERAPEUTICS Corp For: Apr 08 Filed by: ROTHBLATT MARTINE A
April 9, 2026 4:31 PM - SEC Filing
Raymond James Starts United Therapeutics Corp. (UTHR) at Outperform
April 9, 2026 4:17 PM - StreetInsider
Form 4 UNITED THERAPEUTICS Corp For: Apr 07 Filed by: ROTHBLATT MARTINE A
April 8, 2026 4:34 PM - SEC Filing
United Therapeutics receives FDA regenerative medicine designation for liver device
April 8, 2026 7:00 AM - StreetInsider
United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure
April 8, 2026 7:00 AM - BizWire
Form 4 UNITED THERAPEUTICS Corp For: Apr 06 Filed by: EDGEMOND JAMES
April 7, 2026 4:43 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 06 Filed by: ROTHBLATT MARTINE A
April 7, 2026 4:43 PM - SEC Filing
United Therapeutics Corp. (UTHR) PT Raised to $700 at RBC Capital
April 7, 2026 9:06 AM - StreetInsider
Form 4 UNITED THERAPEUTICS Corp For: Apr 02 Filed by: ROTHBLATT MARTINE A
April 6, 2026 4:42 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 02 Filed by: EDGEMOND JAMES
April 6, 2026 4:42 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 02 Filed by: MAHON PAUL A
April 2, 2026 4:36 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Apr 01 Filed by: ROTHBLATT MARTINE A
April 2, 2026 4:35 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 31 Filed by: ROTHBLATT MARTINE A
April 2, 2026 4:34 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: MAHON PAUL A
April 2, 2026 4:09 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: ROTHBLATT MARTINE A
April 1, 2026 4:38 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 30 Filed by: ROTHBLATT MARTINE A
March 31, 2026 4:35 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 30 Filed by: EDGEMOND JAMES
March 31, 2026 4:35 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 30 Filed by: CAUSEY CHRISTOPHER
March 31, 2026 4:33 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 27 Filed by: ROTHBLATT MARTINE A
March 31, 2026 4:33 PM - SEC Filing
United Therapeutics Corp. (UTHR) PT Raised to $660 at H.C. Wainwright
March 31, 2026 9:51 AM - StreetInsider
United Therapeutics Corp. (UTHR) PT Raised to $575 at Wells Fargo
March 31, 2026 6:49 AM - StreetInsider
United Therapeutics (UTHR) call put ratio 3.4 calls to 1 put as share price up 12.5%
March 31, 2026 5:45 AM - StreetInsider
Form 144 UNITED THERAPEUTICS Corp Filed by: CAUSEY CHRISTOPHER
March 30, 2026 5:33 PM - SEC Filing
United Therapeutics Corp. (UTHR) PT Raised to $626 at BofA Securities
March 30, 2026 10:47 AM - StreetInsider
United Therapeutics Corp. (UTHR) PT Raised to $733 at Jefferies
March 30, 2026 10:26 AM - StreetInsider
United Therapeutics Corp. (UTHR) PT Raised to $733 at Jefferies
March 30, 2026 10:26 AM - StreetInsider
United Therapeutics Corp. (UTHR) PT Raised to $660 at TD Cowen, 'remains a top pick'
March 30, 2026 8:33 AM - StreetInsider
Morgan Stanley on United Therapeutics Corp. (UTHR): project Tyvaso '2030/2035 risk-adjusted sales in IPF of $1.2bn/$2.5bn'
March 30, 2026 8:18 AM - StreetInsider
Jefferies on United Therapeutics Corp. (UTHR): expecting '+15–25%' move following positive topline data
March 30, 2026 8:11 AM - StreetInsider
Form 8-K UNITED THERAPEUTICS Corp For: Mar 30
March 30, 2026 7:01 AM - SEC Filing
United Therapeutics TETON-1 study meets primary endpoint for lung disease treatment
March 30, 2026 7:01 AM - StreetInsider
United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2
March 30, 2026 7:00 AM - BizWire
Form 4 UNITED THERAPEUTICS Corp For: Mar 26 Filed by: ROTHBLATT MARTINE A
March 27, 2026 4:32 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 26 Filed by: EDGEMOND JAMES
March 27, 2026 4:32 PM - SEC Filing
Form SCHEDULE 13G/A UNITED THERAPEUTICS Corp Filed by: VANGUARD GROUP INC
March 27, 2026 1:54 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 25 Filed by: ROTHBLATT MARTINE A
March 26, 2026 4:35 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 26 Filed by: Thompson Tommy G
March 26, 2026 4:35 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: Thompson Tommy G
March 26, 2026 4:05 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 24 Filed by: ROTHBLATT MARTINE A
March 25, 2026 4:31 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 23 Filed by: EDGEMOND JAMES
March 24, 2026 4:34 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 23 Filed by: ROTHBLATT MARTINE A
March 24, 2026 4:33 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 23 Filed by: Olian Judy D.
March 24, 2026 4:32 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: EDGEMOND JAMES
March 23, 2026 4:36 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 20 Filed by: ROTHBLATT MARTINE A
March 23, 2026 4:31 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: Olian Judy D.
March 23, 2026 4:01 PM - SEC Filing
United Therapeutics Corp. (UTHR) PT Raised to $486 at Wells Fargo
March 23, 2026 6:59 AM - StreetInsider
Form 4 UNITED THERAPEUTICS Corp For: Mar 19 Filed by: ROTHBLATT MARTINE A
March 20, 2026 4:32 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 18 Filed by: ROTHBLATT MARTINE A
March 19, 2026 4:32 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 19 Filed by: MAHON PAUL A
March 19, 2026 4:31 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: MAHON PAUL A
March 19, 2026 4:05 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 17 Filed by: ROTHBLATT MARTINE A
March 18, 2026 4:34 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 16 Filed by: ROTHBLATT MARTINE A
March 17, 2026 5:11 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 15 Filed by: BENKOWITZ MICHAEL
March 17, 2026 5:11 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 15 Filed by: EDGEMOND JAMES
March 17, 2026 5:10 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 15 Filed by: MAHON PAUL A
March 17, 2026 5:10 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 15 Filed by: ROTHBLATT MARTINE A
March 17, 2026 5:10 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 17 Filed by: MALCOLM JAN
March 17, 2026 4:56 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: MALCOLM JAN
March 17, 2026 4:06 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: Olian Judy D.
March 16, 2026 6:03 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 16 Filed by: Olian Judy D.
March 16, 2026 4:32 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 13 Filed by: ROTHBLATT MARTINE A
March 16, 2026 4:32 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 12 Filed by: ROTHBLATT MARTINE A
March 16, 2026 8:31 AM - SEC Filing
United Therapeutics Corp. (UTHR) PT Raised to $625 at Cantor Fitzgerald on IPF Potential
March 12, 2026 9:11 AM - StreetInsider
Form 4 UNITED THERAPEUTICS Corp For: Mar 11 Filed by: ROTHBLATT MARTINE A
March 11, 2026 7:32 PM - SEC Filing
United Therapeutics publishes positive TETON-2 results in NEJM
March 11, 2026 6:14 PM - StreetInsider
United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine
March 11, 2026 6:14 PM - BizWire
Form 4 UNITED THERAPEUTICS Corp For: Mar 10 Filed by: ROTHBLATT MARTINE A
March 11, 2026 4:32 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 09 Filed by: ROTHBLATT MARTINE A
March 10, 2026 4:34 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 06 Filed by: ROTHBLATT MARTINE A
March 10, 2026 4:34 PM - SEC Filing
Form 8-K UNITED THERAPEUTICS Corp For: Mar 09
March 9, 2026 5:18 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 06 Filed by: Olian Judy D.
March 9, 2026 4:37 PM - SEC Filing
Form 4 UNITED THERAPEUTICS Corp For: Mar 05 Filed by: ROTHBLATT MARTINE A
March 9, 2026 4:37 PM - SEC Filing
Form 144 UNITED THERAPEUTICS Corp Filed by: Olian Judy D.
March 9, 2026 4:04 PM - SEC Filing
TD Cowen on United Therapeutics Corp. (UTHR) Buyback: 'We believe that this signals management's confidence'
March 9, 2026 10:26 AM - StreetInsider
United Therapeutics authorizes $2 billion share buyback program
March 9, 2026 7:00 AM - StreetInsider
United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program
March 9, 2026 7:00 AM - BizWire
Full Article List
